课题基金 / 基金详情

Sustainable Community Clinic Telemedicine-Based Glaucoma Screening

Sustainable Community Clinic Telemedicine-Based Glaucoma Screening
可持续社区诊所基于远程医疗的青光眼筛查
批准号:
10412890
负责人:
Paula Anne Newman-Casey
金额:
$70.0万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-30 至 2023-09-29

项目摘要

项目成果

Paula Anne Newman-Casey的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 迫切需要研究创新战略,以更好地吸引最有可能感染艾滋病毒的人群。 昏迷性视力丧失,最不可能获得眼科护理提供者。社区诊所,如 联邦政府认可的保健中心或免费诊所为生活贫困的人提供护理。因为这些 人们不成比例的少数种族和民族,社区诊所提供照顾的人, 有更高的风险:1)青光眼和2)没有得到足够的专业治疗青光眼。青光眼 仍然是失明的主要原因,尽管存在有效的治疗方法。我们的目标是解决 关键的后勤和心理障碍-成本,运输,对供应商的信任和怀疑, 无症状的疾病会导致失明,这限制了脆弱人群获得青光眼护理的机会。 科学前提是基于远程医疗方法对青光眼有效性的证据 筛查改善了弱势群体获得服务的机会。我们的核心假设是, 通过社区免费诊所提供全面的青光眼筛查和后续护理 基础设施将建立一个可持续的方法,以减少后勤和心理社会问题, 改善这一弱势群体的视力状况。我们将使用社区参与的研究策略, 通过半结构化的方法,了解未投保和投保不足的成年人获得眼科护理的主要障碍 采访我们将建立在学术(密歇根大学,UM)之间的信任伙伴关系, 社区诊所(密歇根州伊普西兰蒂希望诊所和密歇根州弗林特汉密尔顿诊所), 董事会让这些社区参与青光眼筛查工作。我们将使用远程医疗 青光眼筛查方法在两个诊所。眼科技术人员将收集自动眼睛筛查 在临床研究中心收集数据,并将数据传输给UM的眼科医生,由其解释筛选 信息并远程传达推荐的后续护理。眼科医生资源将被更多地使用 这是因为它们不需要与患者共同定位以提供高质量的筛查护理。的 病人的时间负担亦得以减轻。筛查在当地可信地点进行,只有患者 去专科诊所的人。低成本眼镜将通过公开提供 可用的基础设施。我们将评估青光眼和其他致盲性眼病的患病率, 每发现一个病例的筛查费用。我们将利用社区的意见来完善基于电子健康的个性化 咨询和教育计划,以提高对青光眼后续护理建议的依从性。我们 将评估与标准教育相比,这种干预对随访依从性的影响, 随机对照试验。将对方案费用进行评估。这是我们长期以来的第一步- 长期目标是通过利用社区参与的研究, 为弱势群体提供特殊护理。
英文摘要
Project Summary There is a critical need to study innovative strategies to better engage populations of people most at risk of glaucomatous vision loss and least likely to have access to an eye care provider. Community clinics such as federally qualified health centers or free clinics provide care for people who live in poverty. Because these people are disproportionately of minority race and ethnicity, community clinics provide care for people who are at higher risk of: 1) having glaucoma and 2) not getting adequate specialty treatment for glaucoma. Glaucoma remains a leading cause of blindness even though effective treatments exist. Our objective is to address the critical logistical and psychosocial barriers – cost, transportation, trust in the provider and skepticism that that an asymptomatic disease will lead to blindness – that limit access of vulnerable populations to glaucoma care. The scientific premise is based on evidence of the effectiveness of telemedicine approaches to glaucoma screening that have improved access to services for vulnerable populations. Our central hypothesis is that providing comprehensive glaucoma screening and follow-up care through the community-based free clinic infrastructure will establish a sustainable approach to decreasing logistical and psychosocial issues and improve vision outcomes for this vulnerable population. We will use community-engaged research strategies to understand key barriers to accessing eye care for uninsured and underinsured adults through semi-structured interviews. We will build upon a trusting partnership among academic (University of Michigan, UM) and community clinics (Hope Clinic, Ypsilanti, MI and Hamilton Clinic, Flint, MI) by forming a Community Advisory Board to engage these communities in glaucoma screening efforts. We will use a telemedicine-based glaucoma screening approach in the two clinics. Ophthalmic technicians will gather automated eye screening data at the clinic sites and transmit the data to an ophthalmologist at the UM who interprets screening information and conveys recommended follow-up care remotely. Ophthalmologist resources will be used more efficiently, since they do not need to be co-localized with the patient to provide high quality screening care. The burden on patients’ time is also reduced. Screening is conducted locally at trusted locations, and only patients who screen positive for disease travel to specialty clinics. Low-cost glasses will be provided through publicly available infrastructure. We will assess the prevalence of glaucoma and other blinding eye diseases and the screening cost per case detected. We will use community input to refine an eHealth-based personalized counseling and education program to improve adherence to glaucoma follow-up care recommendations. We will evaluate the effect of this intervention on follow-up adherence compared to standard education in a randomized controlled trial. Programmatic costs will be evaluated. This proposal is a first step toward our long- term goal to eliminate disparities in glaucoma outcomes by leveraging community-engaged research to bring specialty care to vulnerable populations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Support, Educate, Empower: The SEE Personalized Glaucoma Coaching Trial
  • 批准号:
    10460450
  • 项目类别:
  • 资助金额:
    $70.64万
  • 财政年份:
    2020
  • 负责人:
    Paula Anne Newman-Casey
  • 依托单位:
Support, Educate, Empower: The SEE Personalized Glaucoma Coaching Trial
  • 批准号:
    10723140
  • 项目类别:
  • 资助金额:
    $14.24万
  • 财政年份:
    2020
  • 负责人:
    Paula Anne Newman-Casey
  • 依托单位:
Support, Educate, Empower: The SEE Personalized Glaucoma Coaching Trial
  • 批准号:
    10232076
  • 项目类别:
  • 资助金额:
    $73.14万
  • 财政年份:
    2020
  • 负责人:
    Paula Anne Newman-Casey
  • 依托单位:
Support, Educate, Empower: The SEE Personalized Glaucoma Coaching Trial: Diversity Supplement
  • 批准号:
    10577970
  • 项目类别:
  • 资助金额:
    $14.05万
  • 财政年份:
    2020
  • 负责人:
    Paula Anne Newman-Casey
  • 依托单位:
海外基金